The tyrosine kinase inhibitor lavandin A has been demonstrated to rapidly regulate dopamine transporters in rat neurons (56); however, it is yet unknown how this inhibits PD and PD-RBD. This evidence concerns the gene SLC6A3 and Parkinson disease.